Literature DB >> 27816632

HPLC method for simultaneous analysis of ticagrelor and its organic impurities and identification of two major photodegradation products.

Lívia Maronesi Bueno1, Joanna Wittckind Manoel2, Camila Ferrazza Alves Giordani2, Andreas Sebastian Loureiro Mendez2, Nadia Maria Volpato2, Elfrides Eva Scherman Schapoval2, Martin Steppe2, Cássia Virginia Garcia2.   

Abstract

A simple, fast and sensitive analytical method by high-performance liquid chromatography (HPLC) was developed and validated for the simultaneous determination of ticagrelor and two synthesis impurities. The HPLC method was established using an Agilent 1200 Series equipment coupled to photodiode array detector (PDA) at 270nm with a Zorbax Plus C8 column (150×4.6mm, 5.0μm), injection volume of 20μL, and a constant temperature of 25°C. The mobile phase consisted of acetonitrile: ammonium acetate 50mM (57:43, v/v) and pH adjusted to 8.2 with ammonium hydroxide 6M, at a flow rate of 0.7mL/min. No interference peaks from excipients and diluent system indicated the specificity of the method. The calibration curves showed determination coefficients (r2)>0.99, calculated by linear regression. The limit of quantitation (LOQ) for impurities 1 and 2 were 2.0 and 0.2μg/mL, respectively. Intra and interday relative standard deviations (RSDs) were <2% for ticagrelor and <6% for the impurities, proving the precision of the method. Besides, two mayor degradation products formed when sample solutions of ticagrelor were exposed to UVC radiation were elucidated and the mechanisms involved in the photolytic degradation of ticagrelor were proposed.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Degradation products; Drug impurities; HPLC; Ticagrelor; Validation

Mesh:

Substances:

Year:  2016        PMID: 27816632     DOI: 10.1016/j.ejps.2016.11.004

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  3 in total

1.  pH-Responsive Nanocomposite Based Hydrogels for the Controlled Delivery of Ticagrelor; In Vitro and In Vivo Approaches.

Authors:  Nariman Shahid; Alia Erum; Muhammad Zaman; Ume Ruqia Tulain; Qurat-Ul-Ain Shoaib; Abdul Majeed; Muhammad F Rasool; Imran Imran; Sultan Alshehri; Behnam Noorani; Faleh Alqahtani
Journal:  Int J Nanomedicine       Date:  2021-09-16

2.  Visualization of the photodegradation of a therapeutic drug by chemometric-assisted fluorescence spectroscopy.

Authors:  Masaru Tanioka; Tsugumi Ebihana; Manae Uraguchi; Haruka Shoji; Yuka Nakamura; Rina Ueda; Shota Ogura; Yoshifumi Wakiya; Tohru Obata; Takahiro Ida; Jun Horigome; Shinichiro Kamino
Journal:  RSC Adv       Date:  2022-07-19       Impact factor: 4.036

3.  Strategic approach to developing a self-microemulsifying drug delivery system to enhance antiplatelet activity and bioavailability of ticagrelor.

Authors:  Young-Guk Na; Jin-Ju Byeon; Miao Wang; Hyun Wook Huh; Gi-Ho Son; Sung-Hoon Jeon; Ki-Hyun Bang; Sung-Jin Kim; Hye-Jin Lee; Hong-Ki Lee; Cheong-Weon Cho
Journal:  Int J Nanomedicine       Date:  2019-02-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.